Vimarsana
Biggest News Aggregation in the World

Autonomous Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Autonomous Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Autonomous Diagnostics Today - Breaking & Trending Today

What is DARPA? | Popular Science - Vimarsana News

What is DARPA? | Popular Science

The Pentagon's research agency dates back to 1958, and was created in response to a surprise from the USSR. Here's what DARPA does.

Source: popsci.com
What is DARPA? The rich history of the Pentagon's secretive tech agency - Vimarsana News

What is DARPA? The rich history of the Pentagon's secretive tech agency

The famous DOD research arm has been working on tech breakthroughs since 1958. Here's how it got started—and what it does now.

Source: yahoo.com
Why COVID-19 Mass Vaccination is a Military Operation - Vimarsana News

Why COVID-19 Mass Vaccination is a Military Operation

The mRNA vaccines were not a product of Operation Warp Speed and developed in just a few months -- rather, DARPA has been working on them with companies such as Moderna since 2011.

Preparing for the Next Plague - Vimarsana News

Preparing for the Next Plague

SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges

DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™ - Vimarsana News

DARPA Awards Moderna Therapeutics a Grant for up to $25 Million to Develop Messenger RNA Therapeutics™

October 2, 2013 at 9:00 AM EDT Research to focus on antibody production for immune defense CAMBRIDGE, Mass., October 2, 2013—Moderna Therapeutics, the company pioneering messenger RNA therapeutics™, a revolutionary new treatment modality to enable the  in vivo production of therapeutic proteins, announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company up to $25 million to research and develop its messenger RNA therapeutics™ platform as a rapid and reliable way to make antibody-producing drugs to protect against a wide range of known and unkno...